Company & Sponsor Intelligence

Boston University Charles River Campus

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed7

Countries1

Therapeutic footprint

anxietyautismdepressionother_psychiatryparkinsons

Indexed studies

NCT03625999A Novel Intervention for Training Auditory Attention in Adolescents With Autism Spectrum Disorder
autism · United StatesNA

NCT04059939Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers
anxiety · United StatesNA

NCT03374072Engaging Siblings of Adults With Autism in Future Planning
autism · United StatesNA

NCT00586001A Unified Treatment for Anxiety Disorders
depression · NA

NCT02700074Brain Mechanisms for Language Processing in Adolescents With Autism Spectrum Disorder
autism · United StatesCOMPLETED

NCT02784938Vocational Empowerment Photovoice (VEP)
other_psychiatry · United StatesNA

NCT03517371Walking and mHealth to Increase Participation in Parkinson Disease
parkinsons · United StatesNA

NCT05965648Development of a Family-Based Transition Planning Program for Culturally-Diverse Youth on the Autism Spectrum
autism · United StatesNA

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →